Literature DB >> 15903000

[Severe Streptococcus agalactiae infection of the diabetic foot. A deleterious role of Streptococcus agalactiae?].

Catherine Altrichter Loan1, Laurence Legout, Mathieu Assal, Peter Rohner, Pierre Hoffmeyer, Louis Bernard.   

Abstract

INTRODUCTION: Screening strategies among pregnant women have decreased the incidence of group B Streptococcus, which causes severe neonatal infections. The incidence of these infections has increased among diabetic patients, however.
OBJECTIVES: To specify the characteristics of diabetic foot infections in which surgical samples have isolated one or several germs including group B Streptococcus, study its risk factors and determine its course.
MATERIALS AND METHODS: We retrospectively evaluated the records of all patients admitted to the University Hospital of Geneva from January 1999 through October 2004, with diagnoses of severe foot infection (+/- osteomyelitis) documented during surgery.
RESULTS: Twenty-five severe diabetic foot infections were identified, 21 with osteomyelitis. The most common risk factors were age older than 60 years (n=10), chronic renal failure (n=7), severe arteriopathy (n=6), and immune depression (n=2). Most lesions were classified as grade 3 or 4 of Wagner's classification. 80% of the surgical samples were polymicrobial. Blood cultures were positive in 4 patients, one in septic shock. Half the patients (n=13) underwent amputation, despite initially appropriate antibiotic treatment. No patients died but 3 relapsed.
CONCLUSION: Group B streptococcal foot infections often occur in fragile patients with immune depression or severe arterial disease. Despite intensive antibiotic therapy and adequate debridement, amputation is often required in diabetic patients because of severe damage to the tissue and poor vascularization.

Entities:  

Mesh:

Year:  2005        PMID: 15903000

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

Review 1.  The treatment of diabetic foot infections: focus on ertapenem.

Authors:  Michael Edmonds
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

2.  Distinct vasculotropic versus osteotropic features of S. agalactiae versus S. aureus implant-associated bone infection in mice.

Authors:  Elysia A Masters; Stephanie P Hao; H Mark Kenney; Yugo Morita; Chad A Galloway; Karen L de Mesy Bentley; Benjamin F Ricciardi; Brendan F Boyce; Edward M Schwarz; Irvin Oh
Journal:  J Orthop Res       Date:  2020-12-29       Impact factor: 3.494

3.  [Bacteriological profile of diabetic foot and its impact on the choice of antibiotics].

Authors:  Adil Zemmouri; Mohamed Tarchouli; Abdellatif Benbouha; Tarik Lamkinsi; Mustapha Bensghir; Mostafa Elouennass; Cherqui Haimeur
Journal:  Pan Afr Med J       Date:  2015-02-17

4.  Clinical and bacteriological profile of diabetic foot infections in a tertiary care.

Authors:  Teik Chiang Goh; Mohd Yazid Bajuri; Sivapathasundaram C Nadarajah; Abdul Halim Abdul Rashid; Suhaila Baharuddin; Kamarul Syariza Zamri
Journal:  J Foot Ankle Res       Date:  2020-06-16       Impact factor: 2.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.